Latest Sales Growth News

Orcoda Limited has lifted its Annual Recurring Revenue by 23% year-on-year to $6.2 million, with a new multi-year Wagner Corporation contract pushing total ARR to $14.2 million as it enters FY27.

RLF AgTech is advancing its commercial growth strategy by expanding its nutrition and biologicals portfolio and rebuilding its Australian sales function, achieving a six-fold increase in customer receipts since early 2026.

Harris Technology (ASX: HT8) reported a 29% sales increase for FY26, driven by its refurbished technology division now contributing 58% of revenue and delivering higher margins. The company also secured a strategic equity conversion from FSP Technology, reinforcing its growth trajectory.

Coast Entertainment has unlocked a major milestone with Queensland Government approval for its Coomera landholding development, while reporting robust FY26 trading with double-digit growth in ticket sales and revenue.

Coventry Group’s Q4 FY26 results show a strong operational turnaround with sales up 11.7% quarter-on-quarter and EBITDA almost doubling to $4.1 million, backed by a $10 million cost reduction program and positive cash flow.

ECP Emerging Growth Limited rebounded in the June quarter with a 6.1% portfolio gain and an 8.4% lift in net tangible asset value, driven by strong performances in AI-related holdings and consumer growth stocks.

Oliver’s Real Food Limited posted a 96% improvement in EBIT for the June 2026 quarter despite an 11.5% revenue drop due to store closures. The company’s focus on operational efficiency and cost control drove EBITDA up 24%, while same-store sales edged higher by 1.09%.

Immuron Limited reported a 6% increase in FY26 sales to AUD 7.7 million, driven by strong gains in Canada and the US despite mixed Australian performance. Marketing initiatives and retail expansion underpin growth.

Freehill Mining’s aggregates business posted a record $1.36 million in quarterly sales, up 47% from the prior quarter, driven by plant improvements and a broadening customer base. June alone saw a record $496,000 in sales, underpinning the company’s copper project ambitions.

Within six weeks of commissioning, Aguia Resources has secured over A$2.3 million in sales of its Pampafos organic phosphate fertiliser, marking a key transition to revenue-generating operations with deliveries scheduled through year-end.

Orthocell Ltd delivered a standout FY26 with 44% revenue growth to A$13.2 million, powered by accelerating US sales of its nerve repair product Remplir and a robust cash position supporting further expansion.

Orthocell Limited has posted record revenue for FY2026, driven by strong sales growth of Remplir™ and Striate+™ products in Australia, the US, and new international markets, supported by a robust $44.1 million cash position.